<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="42386">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02554539</url>
  </required_header>
  <id_info>
    <org_study_id>34225</org_study_id>
    <nct_id>NCT02554539</nct_id>
  </id_info>
  <brief_title>Transciptomic Modification Induced by miRNAs in Endometrial Fluid</brief_title>
  <acronym>miRNA_EF</acronym>
  <official_title>Human Embryonic Transciptomic Modification Induced by miRNAs Secreted by Human Endometrium to Endometrial Fluid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand the mechanism of communication between the
      uterine environment and the preimplantation human embryo. The investigators are interested
      in understanding how the in-utero environment during the window of implantation is different
      in normal weight and overweight/obese women and how this may impact the programming of the
      developing embryo.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gene expression profile in human embryos</measure>
    <time_frame>Samples will be collected within 1 month of enrollment</time_frame>
    <description>We will perform RNA sequencing on the human embryo to quantify which genes are up and down regulated in obese compared to normal weight controls.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>MicroRNA in Endometrial Fluid</condition>
  <arm_group>
    <arm_group_label>Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women, aged 21-45 with BMI &gt;30</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women, aged 21-45 with BMI &lt; 25</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endometrial fluid aspiration</intervention_name>
    <description>Patient will undergo a biopsy to aspirate endometrial fluid from the uterine cavity</description>
    <arm_group_label>Obese</arm_group_label>
    <arm_group_label>Normal weight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet the WHO criteria for normal weight (BMI &lt; 25) and overweight/obese (BMI &gt; 25)

          -  Age 21-45

        Exclusion Criteria:

          -  Age &lt; 21 or &gt; 45

          -  Women with history of hysterectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Meera S Shah</last_name>
    <phone>5106124918</phone>
    <email>shahm@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Lindsay</last_name>
      <phone>650-498-7408</phone>
      <email>tracyl@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 12, 2016</lastchanged_date>
  <firstreceived_date>August 27, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Meera Sridhar Shah</investigator_full_name>
    <investigator_title>Clinical Fellow</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
